4//SEC Filing
Meltz Mark A 4
Accession 0001209191-22-048525
CIK 0001797768other
Filed
Sep 1, 8:00 PM ET
Accepted
Sep 2, 5:00 PM ET
Size
5.2 KB
Accession
0001209191-22-048525
Insider Transaction Report
Form 4
Meltz Mark A
COO General Counsel Treasurer
Transactions
- Award
Common Stock
2022-09-01+25,000→ 28,465 total
Footnotes (2)
- [F1]The Issuer granted RSUs to the Reporting Person. Each RSU represents the Reporting Person's right to receive one share of Common Stock of the Issuer. A portion of the RSUs vest each quarter, subject to the Reporting Person's continued service as of each vesting date.
- [F2]Includes 1,729 shares acquired under the Issuer's Employee Stock Purchase Plan (the "Plan") in May 2021, 595 shares acquired under the Plan in November 2021, and 1,141 shares acquired under the Plan in May 2022.
Documents
Issuer
Kinnate Biopharma Inc.
CIK 0001797768
Entity typeother
Related Parties
1- filerCIK 0001771329
Filing Metadata
- Form type
- 4
- Filed
- Sep 1, 8:00 PM ET
- Accepted
- Sep 2, 5:00 PM ET
- Size
- 5.2 KB